Gene expression profiling for the identification of G-protein coupled receptors in human platelets.

[1]  D. Shi,et al.  Inhibition of platelet aggregation by adenosine receptor agonists , 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  D. Erlinge,et al.  Residual platelet ADP reactivity after clopidogrel treatment is dependent on activation of both the unblocked P2Y1 and the P2Y12 receptor and is correlated with protein expression of P2Y12 , 2006, Purinergic Signalling.

[3]  G. Cavaletti,et al.  Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation , 2006, Neuroscience Letters.

[4]  A. Dubin,et al.  GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5* , 2006, Journal of Biological Chemistry.

[5]  B. Olde,et al.  Lysophosphatidic Acid Binds to and Activates GPR92, a G Protein-Coupled Receptor Highly Expressed in Gastrointestinal Lymphocytes , 2006, Journal of Pharmacology and Experimental Therapeutics.

[6]  T. Schwartz,et al.  Molecular Pharmacological Phenotyping of EBI2 , 2006, Journal of Biological Chemistry.

[7]  U. Walter,et al.  The Human Platelet Membrane Proteome Reveals Several New Potential Membrane Proteins*S , 2005, Molecular & Cellular Proteomics.

[8]  R. I. Myers.  The Variability of Platelet Response to Aspirin and Clopidogrel: Revisiting the Caprie, Cure, Credo, and Match Trials , 2005, Proceedings.

[9]  D. Woulfe.  REVIEW ARTICLES: Platelet G protein‐coupled receptors in hemostasis and thrombosis , 2005, Journal of thrombosis and haemostasis : JTH.

[10]  P. Bugert,et al.  Gene expression analysis in platelets from a single donor: evaluation of a PCR-based amplification technique. , 2004, Clinical chemistry.

[11]  G. Reed.  Platelet secretory mechanisms. , 2004, Seminars in thrombosis and hemostasis.

[12]  S. Kunapuli,et al.  Role of protease‐activated and ADP receptor subtypes in thrombin generation on human platelets , 2004, Journal of thrombosis and haemostasis : JTH.

[13]  S. Kunapuli,et al.  Central role of the P2Y12 receptor in platelet activation. , 2004, The Journal of clinical investigation.

[14]  Dermot F. Reilly,et al.  Integration of Proteomics and Genomics in Platelets , 2004, Molecular & Cellular Proteomics.

[15]  B. Engelmann,et al.  Platelet ADP receptors contribute to the initiation of intravascular coagulation. , 2004, Blood.

[16]  U. Walter,et al.  Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. , 2004, Blood.

[17]  I. Mindukshev,et al.  Effects of Oxytocin and Prostaglandin F2a (Enzaprost) on Platelet Aggregation , 2002, Bulletin of Experimental Biology and Medicine.

[18]  N. Prévost,et al.  Signaling receptors on platelets and megakaryocytes. , 2004, Methods in molecular biology.

[19]  Peter Bugert,et al.  Messenger RNA profiling of human platelets by microarray hybridization , 2003, Thrombosis and Haemostasis.

[20]  R. Bohle,et al.  Characterization of platelet-specific mRNA by real-time PCR after laser-assisted microdissection , 2003, Thrombosis and Haemostasis.

[21]  A. Tager,et al.  BLT1 and BLT2: the leukotriene B(4) receptors. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[22]  Takao Shimizu,et al.  Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family* , 2003, Journal of Biological Chemistry.

[23]  S. Jackson,et al.  Signaling events underlying thrombus formation , 2003, Journal of thrombosis and haemostasis : JTH.

[24]  M. Mortrud,et al.  The G protein-coupled receptor repertoires of human and mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Perrotta,et al.  Transcript profiling of human platelets using microarray and serial analysis of gene expression. , 2003, Blood.

[26]  H. Brogren,et al.  Quantification of ADP and ATP receptor expression in human platelets , 2003, Journal of thrombosis and haemostasis : JTH.

[27]  Gert Vriend,et al.  GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..

[28]  Alan Wise,et al.  Target validation of G-protein coupled receptors. , 2002, Drug discovery today.

[29]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[30]  E. Ongini,et al.  Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects. , 2000, Circulation.

[31]  K. Jacobson,et al.  Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors. , 2000, Journal of medicinal chemistry.

[32]  Y. Igarashi,et al.  Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1‐phosphate , 2000, FEBS letters.

[33]  Brian Savage,et al.  Specific Synergy of Multiple Substrate–Receptor Interactions in Platelet Thrombus Formation under Flow , 1998, Cell.

[34]  Takashi Nakamura,et al.  Platelet Adhesion to Native Type I Collagen Fibrils , 1998, The Journal of Biological Chemistry.

[35]  P. Hjemdahl,et al.  Effects of serotonin on platelet activation in whole blood , 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[36]  L. Brass,et al.  Signaling through G Proteins in Platelets: to the Integrins and Beyond , 1997, Thrombosis and Haemostasis.

[37]  M. G. De Montis,et al.  NMDA Receptors Play an Anti-aggregating Role in Human Platelets , 1996, Thrombosis and Haemostasis.

[38]  Zijian Xie,et al.  Heterogeneity of the aggregation response of human platelets to arginine vasopressin , 1995, American journal of hematology.

[39]  E. Ongini,et al.  2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. , 1994, Journal of medicinal chemistry.

[40]  B. Kehrel,et al.  The Platelet Glycoprotein IIb/IIIa Complex Is lnvolved in the Adhesion of Activated Platelets to Leukocytes , 1993, Thrombosis and Haemostasis.

[41]  G. FitzGerald.  Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. , 1991, The American journal of cardiology.

[42]  V. Fuster,et al.  Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation. , 1988, Circulation.

[43]  C. Legrand,et al.  Studies on Platelets of Patients with Inherited Platelet Disorders Suggest that Collagen-Induced Fibrinogen Binding to Membrane Receptors Requires Secreted ADP but Not Released α-Granule Proteins , 1985, Thrombosis and Haemostasis.

[44]  S. Hourani,et al.  5′‐N‐ETHYLCARBOXAMIDOADENOSINE: A POTENT INHIBITOR OF HUMAN PLATELET AGGREGATION , 1981, British journal of pharmacology.